Patent of the Week: A Low Dose, Multi-Drug Cocktail for Breast Cancer Treatment
More than 150,000 breast cancer survivors were living with metastatic disease, three-fourths of whom were originally diagnosed with stage I-III, as of January 1, 2019, according to the American Cancer Society. Patients with metastatic disease… Keep reading